News | Computed Tomography (CT) | November 19, 2020

CurveBeam Announces FDA 510(K) Clearance for HiRise Weight-bearing CT System

CurveBeam announced the HiRise, its weight bearing CT (WBCT) imaging system for the entire lower extremity, has received FDA 510(K) clearance.

November 19, 2020 — CurveBeam announced the HiRise, its weight bearing CT (WBCT) imaging system for the entire lower extremity, has received FDA 510(K) clearance.

CurveBeam is a leader in weight bearing CT imaging for the orthopedic extremities. CurveBeam systems offer a wide patient platform that lets patients stand naturally on both feet during a scan. CurveBeam’s HiRise can scan anywhere along the lower extremity from the hip and pelvis to the feet. WBCT imaging of the hip and pelvis is a novel application not previously available in any system.

“CurveBeam’s mission is to be responsive to crucial but unmet diagnostic needs of the specialties it serves, and introduction of the HiRise device is the latest transformational step in that direction,” said CurveBeam President and CEO Arun Singh. “This system literally achieves new heights in point of care advanced orthopedic imaging.”

Two HiRise systems were installed for investigational studies prior to FDA clearance at University of Iowa Carver School of Medicine’s Department of Orthopedics and Rehabilitation in Iowa City, IA, and at Tennessee Orthopaedic Clinics (TOC) in Knoxville, TN.

The HiRise gantry tilts for upper extremity imaging and supine lower leg imaging.

Researchers at University of Iowa are using the HiRise for multiple research studies, including examining hip dysplasia in functional position and evaluating wrist injuries in gymnasts.  

“The HiRise promises to revolutionize our biomechanical understanding of the entire lower extremity the same way previous generations of CurveBeam’s weight bearing CT systems enabled better investigation into the foot, ankle and knee,” said Cesar de Cesar Netto, M.D., Ph.D., Assistant Professor of Orthopedics and Rehabilitation at University of Iowa.

CurveBeam’s systems utilize cone beam CT technology and are designed for the orthopedic point-of-care setting. The HiRise plugs into a standard wall outlet, requires minimal shielding, and is easy to operate.

CurveBeam announced CE Marking for the HiRise in October.

For more information: www.curvebeam.com

Related Content

Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in t
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

News | Breast Imaging | February 24, 2021
Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations).
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Detroit-based magnetic resonance...
Findings indicate that PPC and GG are highly predictive of overall upstaging by PSMA PET/CT for patients with high-risk prostate cancer

Image courtesy of UCLA Health

News | PET-CT | February 23, 2021
February 23, 2021 — A...
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | February 22, 2021
February 22, 2021 — According to an...
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in

Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in (a). The bottom row focuses on the detection of small calcifications, a key feature in DCIS. These are undetectable in (d), detected in (e), enhanced in the maximum intensity projection (MIP) image at the bottom of (f), and confirmed by histopathology in the top part of (f). The scale bar [shown in (b) and (e)] is the same for all images apart from (f), which has its own scale. Red arrows in (e) and (f) indicate the microcalcifications. Image courtesy of Professor Alessandro Olivo

News | Breast Imaging | February 22, 2021
February 22, 2021 — A new X-ray imaging scanne
 Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS). 
News | Enterprise Imaging | February 18, 2021
February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired...